Epigenetic Therapy

Epigenetic therapy is meant to use the drugs or Epigenome - influencing techniques to treat medical states. Histone Deactylases(HDACs), which modify histones, and DNA Methyltransferases(DNMTs), which methylate DNA are the two enzymes that are important in epigenetic modifications and key targets for therapy with pharmaceutical drugs. Successful clinical studies carried out for both the enzymes. Epigenetic therapy has shown a strong effectiveness against Hematological Malignancies and Solid Tumors, gaining FDA approval for cutaneous T-cell Lymphoma, ER-positive metastatic Breast Cancer, Myelodysplastic Syndrome, multiple myeloma, and peripheral T-cell lymphoma. Epigenetic Therapy has proven successful for several types of cancer, including Lung Cancer, breast cancer, and Lymphoma.

1. Fear

2. Anxiety

3. Trauma

4. Cardiac dysfunction

5. Schizophrenia

6. Pharmacokinetics Epigenetics

 

    Related Conference of Epigenetic Therapy

    March 18-19, 2024

    5th Global Summit on Oncology and Hematology

    Zurich, Switzerland
    June 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Barcelona, Spain
    July 11-12, 2024

    24th World Congress on Cancer and Diagnostics

    Vancouver, Canada
    July 18-19, 2024

    14th World Congress on Breast Cancer

    Paris, France
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France

    Epigenetic Therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in